Trong số các bệnh lý truyền từ động vật lây sang người, nhất là từ chó và mèo nuôi thì bệnh do nhiễm ấu trùng giun đũa chó mèo vẫn còn đang rất thời sự và đang được nhiều giới khoa học quan tâm do nhiều lý do: (i) Sự phân bố về mặt dịch tễ học và yếu tố nguy cơ chua được đánh giá một cách toàn diện và đầy đủ; (ii) Các triệu chứng, khung chẩn đoán, định nghĩa ca bệnh và điều trị vẫn còn nhiều điều bàn luận và chưa thống nhất giữa các quốc gia; (iii) Sự phối hợp liên ngành thú y và y tế trong kiểm soát bệnh tật vẫn còn nang giải và chưa được quan tâm, nên gánh nặng bệnh tật còn rất cao.

Đó là lý do tại sao hiện nay và hàng ngày có nhiều ấn phẩm công bố về nghiên cứu bệnh do ấu trùng giun đũa cho mèo (Toxocariasis/ Toxocariosis).

1.Abo-Shehada, M. & Herbert, I.V. (1984) Anthelmintic effect of levamisole, ivermectin, albendazole and fendenbazole o­n larval Toxocara canis infection in mice. Research in Veterinary Science36, 87–91. Google Scholar | PubMed

2.Aur, R.J.A., Pratt, C.B. & Johnson, W.W. (1971) Thiabendazole in visceral larva migrans. American Journal of Diseases of Children121, 226–229. Google Scholar | PubMed

3.Bass, J.L., Mehta, K.A., Glickman, L.T. & Eppes, B.M. (1983) Clinically inapparent Toxocara infection in children. New England Journal of Medicine308, 723–724. Google Scholar | PubMed

4.Bass, J.L., Mehta, K.A., Glickman, L.T., Blocker, R. & Eppes, B.M. (1987) Asymptomatic toxocariasis in children. Clinical Pediatrics26, 441–446. CrossRef | Google Scholar | PubMed

Hình 1

5.Beaver, P.C., Snyder, C.H., Carrera, G.M., Dent, J.H. & Lafferty, J.W. (1952) Chronic eosinophilia due to visceral larva migrans. Report of three cases. Pediatrics9, 7–19. Google Scholar | PubMed

6.Benenson, A.S. (Ed.) (1995) Control of communicable diseases manual. 466. pp. 16th edn. American Public Health Association, Washington DC. Google Scholar

7.Buijs, J., Egbers, M.W.E.C., Lokhorst, W.H., Savelkoul, H.F.J. & Nijkamp, F.P. (1995) Toxocara-induced eosinophilic inflammation. American Journal of Respiratory and Critical Care Medicine151, 873–878. CrossRef | Google Scholar | PubMed

8.Buijs, J., Borsboom, G., Renting, M., Hilgersom, W.H.H., Wieringen, J.C., van., Jansen, G. & Neijens, J. (1997) Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school children. European Respiratory Journal10, 1467–1475. CrossRef | Google Scholar | PubMed

9.Cox, D.M. & Holland, C.V. (1998) The relationship between numbers of larvae recovered from the brain of Toxocara canis-infected mice and social behaviour and anxiety in the host. Parasitology116, 579–594. CrossRef | Google Scholar

10.Cuellar, C., Fenoy, S., Aguila, C. & Guillen, J.L. (1990) Evaluation of chemotherapy in experimental toxocarosis by determination of specific immune complexes. Journal of Parasitology64, 279–289. Google Scholar | PubMed

Hình 2

11.Dao, A.H. & Virmani, R. (1986) Visceral larva migrans involving the myocardium: Report of two cases and review of literature. Pediatric Pathology6, 449–456. CrossRef | Google Scholar | PubMed

12.Delgado, O., Botto, C., Mattei, R. & Escalante, A. (1989) Effect of albendazole in experimental toxocariasis of mice. Annals of Tropical Medicine and Parasitology83, 621–624. CrossRef | Google Scholar

13.Dubinsky, P. (1999) New approaches to control larval toxocarosis. Helminthologia36, 159–165. Google Scholar

14.Dunsmore, J.D., Thompson, R.C.A. & Bates, I.A. (1983) The accumulation of Toxocara canis larvae in the brains of mice. International Journal for Parasitology13, 517–521. CrossRef | Google Scholar

15.Feldman, G.J. & Parker, H.W. (1992) Visceral larva migrans associated with the hypereosinophilic syndrome and the o­nset of severe asthma. Annals of Internal Medicine116, 838–840. CrossRef | Google Scholar | PubMed

16.Fok, E. & Rozgonyi, F. (1999) Epidemiology and public health consequences of human toxocariasis as a frequently occuring urban zoonosis. Orvosi Hetilap140, 1513–1518. Google Scholar

17.Friedman, S. & Hervada, A.R. (1960) Severe myocarditis with recovery in a child with visceral larva migrans. Journal of Pediatrics56, 91–96. CrossRef | Google Scholar

18.Gillespie, S.H., Lewis, J.W. & Maizels, R.M. (1993) The clinical spectrum of human toxocariasis. pp. 55–61. inLewis, J.W. & Maizels, R.M. (Eds) Toxocara and toxocariasis. London, Institute of Biology and the British Society for Parasitology. Google Scholar | PubMed

19.Glickman, L.T. & Schantz, P.M. (1981) Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiologic Reviews3, 230–250. CrossRef | Google Scholar | PubMed

20.Glickman, L.T., Magnaval, J.F., Domanski, L.M., Shofer, F.S., Lauria, S.S., Gottstein, B. & Brochier, B. (1987) Visceral larva migrans in French adults. American Journal of Epidemiology125, 1019–1034. CrossRef | Google Scholar | PubMed

21.Helwigh, A.B., Lind, P. & Nansen, P. (1999) Visceral larva migrans: migratory pattern of Toxocara canis in pigs. International Journal for Parasitology29, 559–565. CrossRef | Google Scholar | PubMed

Hình 3+4

22.Hill, I.R., Denham, D.A. & Scholtz, C.L. (1985) Toxocara canis larvae in the brain of a British child. Transactions of the Royal Society of Tropical Medicine and Hygiene79, 351–354. CrossRef | Google Scholar | PubMed

23.Hokibara, S., Takamoto, M., Isobe, M. & Sugane, K. (1998) Effects of monoclonal antibodies to adhesion molecules o­n eosinophilic myocarditis in Toxocara canis-infected CBA/J mice. Clinical and Experimental Immunology114, 236–244. CrossRef | Google Scholar | PubMed

24.Hotez, P.J. (1993) Visceral and ocular larva migrans. Seminars in Neurology13, 175–179. CrossRef | Google Scholar | PubMed

25.Jacquier, P., Gottstein, B., Singelin, Y. & Eckert, J. (1991) Immunodiagnosis of toxocarosis in humans. Evaluation of a new enzyme-linked immunosorbent assay kit. Journal of Clinical Microbiology29, 1831–1835. Google Scholar | PubMed

26.Jones, R.E., Finkelman, F.D., Hester, R.B. & Kayes, S.G. (1994) Failure to find IgE receptors (FcR) o­n eosinophils from infected mice suggests that murine eosinophils do not kill helminth larvae by an IgE-dependent mechanism. Experimental Parasitology78, 64–75. CrossRef | Google Scholar

27.Kazura, J.W. & Mahmoud, A.A. (1997) Visceral larva migrans and other tissue nematodes. pp. 125–133. inMahmoud, A.A. (Ed.) Parasitic lung diseases. New York, Marcel Dekker Inc. Google Scholar

Hình 5

28.Kayes, S.G. & Freedman, D.O. (1997) Human toxocariasis and the visceral larva migrans syndrome: correlative immunopathology. pp. 99–124. inFreedman, D.O. (Ed.) Immunopathogenic aspects of disease induced by helminth parasites. Chemical immunology. Basel, Karger. CrossRef | Google Scholar

29.Kendell, K.R., Day, J.D., Hruban, R.H., Olson, J.L., Rosenblum, W.D., Kasper, E.K., Baughman, K.L. & Hutchins, G.M. (1995) Intimate association of eosinophils to collagen bundles in eosinophilic myocarditis and ranitine-induced hypersensitivity myocarditis. Archives of Pathology and Laboratory Medicine119, 1154–1160. Google Scholar | PubMed

30.Kincekova, J., Reiterova, K. & Dubinsky, P. (1999) Larval toxocariasis and its clinical manifestation in childhood in the Slovak Republic. Journal of Helminthology73, 323–328. Google Scholar | PubMed

31.Kraus, A., Valencia, X., Cabral, A.R. and de la, Vega, G. (1995) Visceral larva migrans mimicking rheumatic diseases. Journal of Rheumatology22, 497–500. Google Scholar | PubMed

32.Le Lauyer, B., Menager, V., AndebertC., Le C., Le, Ropux, P., Briguet, M.T. & Boulloche, J. (1990) Inflamatory joint disease as a manifestation of Toxocara canis larva migrans. Annales de Pediatrie37, 445–448. Google Scholar

33.Ŀużna-Lyskov, A. (2000) Toxocarosis in children living in a highly contaminated area. An epidemiological and clinical study. Acta Parasitologica45, 40–42. Google Scholar

34.Ŀużna-Lyskov, A., Andrzejewska, I., Lesicka, U., Szewczyk-Kramska, B., Luty, T. & Pawlowski, Z. (2000) Clinical interpretation of eosinophilia and ELISA values (OD) in toxocarosis. Acta Parasitologica45, 35–39. Google Scholar

Hình 6

35.Magnaval, J.F. (1987) Elements nouveaux dans la sémiologie des larva migrans viscérales. Presse Médicale16, 151–154. Google Scholar

36.Magnaval, J.F. (1995) Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology110, 529–533. CrossRef | Google Scholar | PubMed

37.Magnaval, J.F., Baixench, M.T., Lewis, J.W. & Maizels, R.M. (1993) Toxocariasis in the Midi-Pyrénées region. pp. 63–69. inLewis, J.W. & Maizels, R.M. (Eds) Toxocara and toxocariasis. London, Institute of Biology and the British Society for Parasitology.Google Scholar | PubMed

38.Magnaval, J.F., Charlet, J.P. and de, Larrard, B. (1992) Etude double aveugle de l'efficacité du mebendazole dans les formes mineures de la toxocarose humaine. Therapie47, 145–148. Google Scholar

39.Magnaval, J.F., Fabre, R., Mauriéres, P., Charlet, J.P. and de, Larrard, B. (1992) Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and post-treatment follow-up of human toxocariasis. Journal of Clinical Microbiology30, 2269–2274. Google Scholar

40.Magnaval, J.F., Glickman, L.T. & Dorchies, P. (1994) La toxocarose, une zoonose helminthique majeure. Revue de Médecine Véterinaire145, 611–627. Google Scholar

41.Magnaval, J.F., Galindo, V., Glickman, L.T. & Clanet, M. (1997) Human Toxocara infection of the central nervous system and neurological disorders: a case-control study. Parasitology115, 537–543. CrossRef | Google Scholar | PubMed

42.Magnaval, J.F., Dorchies, P. & Morassin, B. (2000) Actualités de la toxocarose humaine. Pyrexie4, 111–115. Google Scholar

43.Meeusen, E.N.T. & Balic, A. (2000) Do eosinophils have a role in the killing of helminth parasites?. Parasitology Today16, 95–101. CrossRef | Google Scholar | PubMed

44.Mikulecky, M. & Mikulecky, M. (1994) A biometrical view o­n chemotherapy of toxocariasis. Acta Pediatrica83, 1232. CrossRef | Google Scholar | PubMed

45.Obwaller, A., Auer, H., Jensen-Jarolim, E., Leitner, A., Kraft, D. & Aspoeck, H. (1996) Die diagnostische Bedeutung des Nachweises specifischer IgE- Antikoerper bei Toxocara-Infestationen. Mitteilungen der Oesterreichischen Gesellschaft für Tropenmedizin und Parasitologie18, 201–206. Google Scholar

Hình 7

46.Obwaller, A., Jensen-Jarolim, E., Auer, H., Huber, A., Kraft, D. & Aspoeck, H. (1998) Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunology20, 311–317. CrossRef | Google Scholar

47.Petithory, J.C., Beddok, A. & Quedoc, M. (1994) Zoonoses d'origine ascaridienne: les syndromes de larva migrans visceral. Bulletin de l'Academie Nationale de Medicine178, 635–647. Google Scholar

48.Phan, S.H. & Kunkel, S.L. (1992) Lung cytokine production in bleomycin-induced pulmonary fibrosis. Experimental Lung Research18, 29–43. CrossRef | Google Scholar | PubMed

49.Skerrett, H. & Holland, C.V. (1997) Variations in the larval recovery of Toxocara canis from the murine brain: implications for behavioural studies. Journal of Helminthology71, 253–255. CrossRef | Google Scholar

50.Stürchler, D., Schubarth, P., Gualzata, M., Gottstein, B. & Oettli, A. (1989) Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Annals of Tropical Medicine and Parasitology83, 473–478. CrossRef | Google Scholar | PubMed

51.Taylor, M.R., Keane, C.T., O'Connor, P., Girdwood, A. & Smith, H. (1987) Clinical features of covert toxocariasis. Scandinavian Journal of Infectious Diseases19, 693–696. CrossRef | Google Scholar | PubMed

52.Taylor, M.R.H., Keane, C.T., O'Connor, P., Mulvihill, E. & Holland, C. (1988) The expanded spectrum of toxocaral disease. Lancet1, 692–694. CrossRef | Google Scholar | PubMed

53.Thompson, D.E., Bundy, D.A.P., Cooper, E.S. & Schantz, P.M. (1986) Epidemiological characteristics of Toxocara canis zoonotic infection of children in a Caribbean community. Bulletin of the World Health Organization21, 283–290. Google Scholar

54.Vegh, M. & Danka, J. (1987) Das Krankheitsbild und die Behandlung der Toxocara-canis-Uveitis im Kindesalter. Klinische Monatsblatter für Augenheilkunde191, 395–396. CrossRef | Google Scholar

55.Wade, S.E. & Georgi, J.R. (1987) Radiolabeling and autoradiographic tracing of Toxocara canis larvae in male mice. Journal of Parasitology73, 116–120. CrossRef | Google Scholar | PubMed

Hình 8

56.Wiseman, R.A., Woodruff, A.W. & Pettitt, L.E. (1971) The treatment of toxocaral infection: some experimental and clinical observations. Transactions of the Royal Society of Tropical Medicine and Hygiene65, 591–598. CrossRef | Google Scholar | PubMed

57.Wolfrom, E., Chene, G., Boisseau, H., Beylot, C., Geniaux, M. & Taieb, A. (1995) Chronic urticaria and Toxocara canis. Lanceti(345), 196. CrossRef | Google Scholar

58.World Health Organization (1995). WHO model prescribing information. Drugs used in parasitic diseases. Geneva,WHO. Google Scholar

59.Żdotarnowska, H., Basiak, W. & Dziubek, Z. (1995). Specific and total serum IgE in ocular and visceral forms of human toxocarosis. Acta Parasitologica40, 62–65. Google Scholar.

60.Alderete JM, Jacob CM, Pastorino AC, Elefant GR, Castro AP, Fomin AB, Chieffi PP. Prevalence of Toxocara infection in schoolchildren from the Butanta region, Sao Paulo, Brazil. Mem Inst Oswaldo Cruz. 2003;98:93–597. doi: 10.1590/S0074-02762003000500002. [PubMed][Cross Ref]

61.Bass JL, Mehta KA, Glickman LT, Blocker R, Eppes BM. Asymptomatic toxocariasis in children. A prospective study and treatment trial. Clin Pediatr (Phila) 1987;26:441–446. doi: 10.1177/000992288702600902. [PubMed][Cross Ref]

62.Bass JL, Mehta KA, Glickman LT, Eppes BM. Clinically inapparent Toxocara infection in children. N Engl J Med. 1983;24:723–724. [PubMed]

63.Beaver PC, Snyder CH, Carrera GM, Dent JH, Lafferty JW. Chronic eosinophilia due to visceral larva migrans: report of three cases. Pediatrics. 1952;9:7–19. [PubMed]

64.Buijs J, Borsboom G, Renting M, Hilgersom WJ, Wieringen JC, Jansen G, Neijens J. Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school children. Eur Respir J. 1997;10:1467–1475. doi: 10.1183/09031936.97.10071467. [PubMed][Cross Ref]

65.Buijs J, Borsboom G, Gemund JJ, Hazebroek A, Dongen PA, Knapen F, Neijens HJ. Toxocara seroprevalence in 5-year-old elementary schoolchildren: relation with allergic asthma. Am J Epidemiol. 1994;140:839–847. [PubMed]

66.Buijs J, Egbers MW, Lokhorst WH, Savelkoul HF, Nijkamp FP. Toxocara-induced eosinophilic inflammation. Airway function and effect of anti-IL-5. Am J Respir Critl Care Med. 1995;151:873–978. [PubMed]

67.Campos Júnior D, Elefant GR, Melo e Silva EO, Gandolfi L, Jacob CM, Tofeti A, Pratesi R. Frequency of seropositivity to Toxocara canis in children of different socioeconomic strata. Rev Soc Bras Med Trop. 2003;36:509–513. doi: 10.1590/S0037-86822003000400013. [PubMed][Cross Ref]

68.Central Statistical and Information (2009) http://demografia.stat.gov.pl/BazaDemografia/Tables.aspx

69.Chomel BB, Kasten R, Adams C, Lambillotte D, Theis J, Goldsmith R, Koss J, Chioino C, Widjana DP, Sutisna P. Serosurvey of some major zoonotic infections in children and teenagers in Bali, Indonesia. Southeast Asian J Trop Med Public Health. 1993;24:321–326. [PubMed]

70.Cielecka B, Majda-Stanislawska E, Kuszewski W (2003) Częstość występowania inwazji Toxocara u dzieci w regionie łódzkim i jej znaczenie kliniczne. Materiały Sympozjum “Parazytozy—problemy kliniczne”, Białystok, 06.06.2003, 62-63

71.Conde Garcia L, Muro Alvarez A, Simon Martin F. Epidemiological studies o­n toxocariasis and visceral larva migrans in a zone of western Spain. Ann Trop Med Parasitol. 1998;83:615–620. [PubMed]

72.Cooper PJ. Interactions between helminth parasites and allergy. Curr Opin Allergy Clin Immunol. 2009;9:29–37. doi: 10.1097/ACI.0b013e32831f44a6. [PMC free article][PubMed][Cross Ref]

73.Dent DH, Nichols RL, Beaver PC, Carrera GM, Staggers RJ. Visceral larva migrans with case report. Am J Pathol. 1956;32:777–803. [PMC free article][PubMed]

74.Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–272. doi: 10.1128/CMR.16.2.265-272.2003. [PMC free article][PubMed][Cross Ref]

75.Deutz A, Fuchs K, Auer H, Kerbl U, Aspöck H, Kofer J. Toxocara-infestations in Austria: a study o­n the risk of infection of farmers, slaughterhouse staff, hunters and veterinarians. Parasitol Res. 2005;97:390–394. doi: 10.1007/s00436-005-1469-5. [PubMed][Cross Ref]

76.Dobosz S, Marczynska M, Popielska J, Żarnowska-Prymek H. Toksokaroza u dzieci w Polsce—powód diagnostyki i objawy kliniczne. Ped Wsp Gastroenterol Hepatol Żywienie Dziecka. 2007;9:247–250.

77.Doğan N, Dinleyici EC, Bor O, Töz SO, Ozbel Y. Seroepidemiological survey for Toxocara canis infection in the northwestern part of Turkey. Türkiye Parazitol Der. 2007;31:288–291. [PubMed]

78.Fan CK, Liao CW, Kao TC, Li MH, Du WY, Su KE. Sero-epidemiology of Toxocara canis infection among aboriginal schoolchildren in the mountainous areas of north-eastern Taiwan. Ann Trop Med Parasitol. 2005;99:593–600. doi: 10.1179/136485905X51373. [PubMed][Cross Ref]

79.Figueiredo SD, Taddei JA, Menezes JJ, Novo NF, Silva EO, Cristovao HL, Cury MC. Clinical–epidemiological study of toxocariasis in a pediatric population. J Pediatr (Rio J) 2005;81:126–132. [PubMed]

80.Fillaux J, Santillan G, Magnaval JF, Jensen O, Larrieu E, Sobrino-Becaria CD. Epidemiology of toxocariasis in a steppe environment: the Patagonia study. Am J Trop Med Hyg. 2007;76:1144–1147. [PubMed]

81.Gavignet B, Piarroux R, Aubin F, Millon L, Humbert P. Cutaneous manifestations of human toxocariasis. J Am Acad Dermatol. 2008;59:1031–1042. doi: 10.1016/j.jaad.2008.06.031. [PubMed][Cross Ref]

82.Gawor J, Borecka A, Dobosz S, Marczyńska M, Zarnowska-Prymek H, Trzebicka A, Juszko J. Toksokaroza dzieci—trudny problem kliniczny. Przegl Epidemiol. 2008;62:407–413. [PubMed]

83.Gillespie S. Toxocara: dogwalking and playing fields. Br J Sports Med. 2001;35:6–7. doi: 10.1136/bjsm.35.1.6. [PMC free article][PubMed][Cross Ref]

84.Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol Rev. 1981;3:230–250. [PubMed]

85.Glickman LT, Shofer FS. Zoonotic visceral and ocular larva migrans. Vet Clin North Am Small Anim Pract. 1987;17:39–53. [PubMed]

86.Gueglio B, Gentile L, Nguyen JM, Achard J, Chabasse D, Marjolet M. Epidemiologic approach to human toxocariasis in western France. Parasitol Res. 1994;80:531–536. doi: 10.1007/BF00932703. [PubMed][Cross Ref]

87.Hermanowska-Szpakowicz T, Kondrusik M, Swierzbińska R, Zajkowska J, Pancewicz S. Incidence of antibody detection against Toxocara canis and clinical symptoms in inhabitants of north-eastern Poland. Pol Merkur Lekarski. 2001;10:168–170. [PubMed]

88.Horak P, Tummeleht L, Talvik H. Predictors and markers of resistance to neurotropic nematode infection in rodent host. Parasitol Res. 2005;98:396–402. doi: 10.1007/s00436-006-0142-y. [PubMed][Cross Ref]

89.Humbert P, Niezborala M, Salembier R, Aubin F, Piarroux R, Buchet S, Barale T. Skin manifestations associated with toxocariasis: a case–control study. Dermatology. 2000;201:230–234. doi: 10.1159/000018493. [PubMed][Cross Ref]

90.Jacquier P, Gottstein B, Stingelin Y, Eckert J. Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kit. J Clin Microbiol. 1991;29:1831–1835. [PMC free article][PubMed]

91.Juszko J, Marczyńska M, Zarnowska H. Diagnostyka i leczenie postaci ocznej infekcji larwa glisty psiej Toxocara canis. Klin Oczna. 1994;96:275–280. [PubMed]

92.Knapen F, Leusden J, Polderman AM, Franchimont JH. Visceral larva migrans: examinations by means of enzyme-linked immunosorbent assay of human sera for antibodies to excretory–secretory antigens of the second-stage larvae of Toxocara canis. Parasitol Res. 1983;69:113–118. [PubMed]

93.Luzna-Lyskov A. Toxocarosis in children living in a highly contaminated area. An epidemiological and clinical study. Acta Parasitol. 2000;45:40–42.

94.Madej T, Jędrzejewski G, Woźniak M, Kryza R, Zielonka E, Wieczorek P. Sprawozdanie z badań prowadzonych w ramach Ogólnopolskiego Programu Profilaktycznych Badań Ultrasonograficznych. Pol Przegl Radiol. 2007;72(Suppl. 1):S142–S142.

95.Maetz HM, Kleinstein RN, Federico D, Wayne J. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 1987;156:414. doi: 10.1093/infdis/156.2.414. [PubMed][Cross Ref]

96.Magnaval JF, Baixench MT. Toxocariasis in the Midi-Pyrénées region. In: Lewi JW, Maizels RM, editors. Toxocara and toxocariasis. London: British Society for Parasitology; 1993. pp. 63–69.

97.Magnaval JF, Fabre R, Maurières P, Charlet JP, Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991;77:697–702. doi: 10.1007/BF00928685. [PubMed][Cross Ref]

98.Magnaval JF, Fabre R, Maurières P, Charlet JP, Larrard B. Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis. J Clin Microbiol. 1992;30:2269–2274. [PMC free article][PubMed]

99.Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1–11. doi: 10.3347/kjp.2001.39.1.1. [PMC free article][PubMed][Cross Ref]

100.Magnaval JF, Michault A, Calon N, Charlet JP. Epidemiology of human toxocariasis in La Réunion. Trans R Soc Trop Med Hyg. 1994;88:531–533. doi: 10.1016/0035-9203(94)90148-1. [PubMed][Cross Ref]

101.Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003;3:733–744. doi: 10.1038/nri1183. [PubMed][Cross Ref]

102.Majkowska-Wojciechowska B, Laskowska B, Wojciechowski Z, Kowalski ML. Występowanie alergii wśród dzieci łódzkich szkól podstawowych: związek z warunkami środowiska domowego i szkolnego. Alergia Astma Immunologia. 2000;5:115–122.

103.Mizgajska H. Zanieczyszczenie gleby jajami Toxocara spp. Na terenie Krakowa i pobliskich wsi. Wiad Parazytol. 2000;46:105–110. [PubMed]

104.Mizgajska H, Jarosz W, Rejmenciak A. Rozmieszczenie źródeł inwazji Toxocara spp. Wśrodowisku miejskim i wiejskim w Polsce. Wiad Parazytol. 2001;47:399–404. [PubMed]

105.Okulewicz A, Złotorzycka J. Toxocara canis (Nematoda) oraz toksokarozy zwierząt i człowieka. Wiad Parazytol. 1997;43:3–25. [PubMed]

106.Osoegawa M. Diagnosis and treatment of CNS parasite infection with special reference to parasitic myelitis. Rinsho Shinkeigaku. 2004;44:961–964. [PubMed]

107.Oteifa NM, Moustafa MA, Elgozamy BM. Toxocariasis as a possible cause of allergic diseases in children. J Egypt Soc Parasitol. 1998;28:365–372. [PubMed]

108.Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75:299–305. doi: 10.1017/S0022149X01000464. [PubMed][Cross Ref]

109.Pawłowski ZS, Mizgajska H. Toksokaroza w Wielkopolsce w latach 1990–2000) Przegl Epidemiol. 2002;56:559–565. [PubMed]

110.Roddie G, Stafford P, Holland C, Wolfe A. Contamination of dog hair with eggs of Toxocara canis. Vet Parasitol. 2008;25:85–93. doi: 10.1016/j.vetpar.2007.12.008. [PubMed][Cross Ref]

111.Schantz PM. Toxocara larva migrans now. Am J Trop Med Hyg. 1989;41(Suppl. 3):S21–S34.

112.Sugane K, Oshima T. Activation of complement in C-reactive protein positive sera by phosphorylcholine-bearing component isolated from parasite extract. Parasite Immunol. 1983;5:385–395. doi: 10.1111/j.1365-3024.1983.tb00754.x. [PubMed][Cross Ref]

113.Taylor MR, Keane CT, O'Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet. 1988;26:692–695. doi: 10.1016/S0140-6736(88)91486-9. [PubMed][Cross Ref]

114.Uhlíková M, Hübner J, Kolárová L, Polácková M. Immunological studies o­n human larval toxocarosis. Cent Eur J Public Health. 1996;4:242–245. [PubMed]

115.Wilder HC. Nematode endophthalmitis. Transactions. Am Acad Ophthalmol Otolaryngol. 1950;55:99–109. [PubMed]

116.Wnukowska N, Bitkowska E, Dzbeński TH (2003) Serologiczna weryfikacja klinicznych rozpoznań toksokarozy u 1374 osób badanych w latach 1995–2002. Materiały Sympozjum “Parazytozy—problemy kliniczne”, Białystok, 06.06.2003, 99

117.Żarnowska H, Borecka A, Gawor J, Marczyńska M, Dobosz S, Basiak W. A serological and epidemiological evaluation of risk factors for toxocariasis in children in central Poland. J Helminthol. 2008;82:123–127. [PubMed].

118.Wilder HC. Nematode endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol 1950; 55: 99–109.

119.Nichols RL. The etiology of visceral larva migrans. I. Diagnostic morphology of infective second-stage Toxocara larvae. J Parasitol 1956; 42: 349–62.

120.Taylor MR, Keane CT, O’Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet 1988; 1: 692–95.

121.Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 2007; 49: 279–87.

122.Pivetti-Pezzi P. Ocular toxocariasis. Int J Med Sci 2009; 6: 129–30.

123.Overgaauw PA. Aspects of Toxocara epidemiology: human toxocarosis. Crit Rev Microbiol 1997; 23: 215–31.

124.Hotez PJ, Wilkins PP. Toxocariasis: America’s most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis 2009; 3: e400.

125.Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol 2010; 104: 3–23.

126.Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol 2013; 43: 999–1008.

127.Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocariasis in North America: a systematic review. PLoS Negl Trop Dis 2014; 8: e3116.

128.Fialho PM, Corrêa CR. A systematic review of toxocariasis: a neglected but high-prevalence disease in Brazil. Am J Trop Med Hyg 2016; 94: 1193–99.

129.Cooper PJ. Toxocara canis infection: an important and neglected environmental risk factor for asthma? Clin Exp Allergy 2008; 38: 551–53.

130.Smith H, Holland C, Taylor M, Magnaval JF, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol 2009; 25: 182–88.

131.Othman AA. Therapeutic battle against larval toxocariasis: are we still far behind? Acta Trop 2012; 124: 171–78.

132.Çelik T, Kaplan Y, Ataş E, Öztuna D, Berilgen S. Toxocara seroprevalence in patients with idiopathic Parkinson’s disease: chance association or coincidence? Biomed Res Int 2013; 2013: 685196.

133.Fan CK, Holland CV, Loxton K, Barghouth U. Cerebral toxocariasis: silent progression to neurodegenerative disorders? Clin Microbiol Rev 2015; 28: 663–86.

134.Holland CV. Knowledge gaps in the epidemiology of Toxocara: the enigma remains. Parasitology 2017; 144: 81–94.

135.Poulsen CS, Skov S, Yoshida A, et al. Differential serodiagnostics of Toxocara canis and Toxocara cati—is it possible? Parasite Immunol 2015; 37: 204–07.

136.Le TH, Anh NT, Nguyen KT, Nguyen NT, Thuy do TT, Gasser RB. Toxocara malaysiensis infection in domestic cats in Vietnam: An emerging zoonotic issue? Infect Genet Evol 2016; 37: 94–98.

137.Hayashi E, Tuda J, Imada M, Akao N, Fujita K. The high prevalence of asymptomatic Toxocara infection among schoolchildren in Manado, Indonesia. Southeast Asian J Trop Med Public Health 2005; 36: 1399–406.

138.Won KY, Kruszon-Moran D, Schantz PM, Jones JL. National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Am J Trop Med Hyg 2008; 79: 552–57.

139.Fu CJ, Chuang TW, Lin HS, et al. Seroepidemiology of Toxocara canis infection among primary schoolchildren in the capital area of the Republic of the Marshall Islands. BMC Infect Dis 2014; 14: 261.

140.Gibbons LM, Jacobs DE, Sani RA. Toxocara malaysiensis n. sp. (Nematoda: Ascaridoidea) from the domestic cat (Fexnaeus, 1758). J Parasitol 2001; 87: 660–65.

141.Fisher M. Toxocara cati: an underestimated zoonotic agent. Trends Parasitol 2003; 19: 167–70.

142.Schnieder T, Laabs EM, Welz C. Larval development of Toxocara canis in dogs. Vet Parasitol 2011; 175: 193–206.

143.Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM. Toxoplasma gondii and Toxocara spp. co-infection. Am J Trop Med Hyg 2008; 78: 35–39.

144.Roddie G, Stafford P, Holland C, Wolfe A. Contamination of dog hair with eggs of Toxocara canis. Vet Parasitol 2008; 152: 85–93.

145.Overgaauw PA, van Zutphen L, Hoek D, et al. Zoonotic parasites in fecal samples and fur from dogs and cats in the Netherlands. Vet Parasitol 2009; 163: 115–22.

146.El-Tras WF, Holt HR, Tayel AA. Risk of Toxocara canis eggs in stray and domestic dog hair in Egypt. Vet Parasitol 2011; 178: 319–23.

147.Burke TM, Roberson EL. Prenatal and lactational transmission of Toxocara canis and Ancylostoma caninum: experimental infection of the bitch at midpregnancy and at parturition. Int J Parasitol 1985; 15: 485–90.

148.Burke TM, Roberson EL. Prenatal and lactational transmission of Toxocara canis and Ancylostoma caninum: experimental infection of the bitch before pregnancy. Int J Parasitol 1985; 15: 71–75.

149.Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol 2001; 75: 299–305.

150.Strube C, Heuer L, Janecek E. Toxocara spp. infections in paratenic hosts. Vet Parasitol 2013; 193: 375–89.

151.Salem G, Schantz P. Toxocaral visceral larva migrans after ingestion of raw lamb liver. Clin Infect Dis 1992; 15: 743–44.

152.Yoshikawa M, Nishiofuku M, Moriya K, et al. A familial case of visceral toxocariasis due to consumption of raw bovine liver. Parasitol Int 2008; 57: 525–29.

153.Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003; 16: 265–72.

154.Kuenzli E, Neumayr A, Chaney M, Blum J. Toxocariasis-associated cardiac diseases—a systematic review of the literature. Acta Trop 2016; 154: 107–20.

155.Martínez-Pulgarin DF, Munoz-Urbano M, Gomez-Suta DL, Delgado OM, Rodriguez-Morales AJ. Ocular toxocariasis: new diagnostic and therapeutic perspectives. Recent Pat Antiinfect Drug Discov 2015; 10: 35–41.

156.Deshayes S, Bonhomme J, de La Blanchardière A. Neurotoxocariasis: a systematic literature review. Infection 2016; 44: 565–74.

157.Caldera F, Burlone ME, Genchi C, Pirisi M, Bartoli E. Toxocara encephalitis presenting with autonomous nervous system involvement. Infection 2013; 41: 691–94.

158.Walsh MG, Haseeb MA. Reduced cognitive function in children with toxocariasis in a nationally representative sample of the United States. Int J Parasitol 2012; 42: 1159–63.

159.Walsh MG, Haseeb MA. Toxocariasis and lung function: relevance of a neglected infection in an urban landscape. Acta Parasitol 2014; 59: 126–31.

160.Mendonça LR, Veiga RV, Dattoli VC, et al. Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American. PLoS Negl Trop Dis 2012; 6: e1886.

161.Li L, Gao W, Yang X, et al. Asthma and toxocariasis. Ann Allergy Asthma Immunol 2014; 113: 187–92.

162.Smith HV, Noordin R. Diagnostic limitations and future trends in the serodiagnosis of human toxocariasis. In: Holland CV, Smith HV, eds. Toxocara: the enigmatic parasite. Wallingford: CABI, 2006; 89–112.

163.Gasser RB. Molecular tools—advances, opportunities and prospects. Vet Parasitol 2006; 136: 69–89.

164.Gasser RB. A perfect time to harness advanced molecular technologies to explore the fundamental biology of Toxocara species. Vet Parasitol 2013; 193: 353–64.

165.Jacobs DE, Zhu X, Gasser RB, Chilton NB. PCR-based methods for identification of potentially zoonotic ascaridoid parasites of the dog, fox and cat. Acta Trop 1997; 68: 191–200.

166.Jex AR, Waeschenbach A, Littlewood DT, Hu M, Gasser RB. The mitochondrial genome of Toxocara canis. PLoS Negl Trop Dis 2008; 2: e273.

167.Li MW, Lin RQ, Song HQ, Wu XY, Zhu XQ. The complete mitochondrial genomes for three Toxocara species of human and animal health significance. BMC Genomics 2008; 9: 224.

168.Wickramasinghe S, Yatawara L, Rajapakse RP, Agatsuma T. Toxocara vitulorum (Ascaridida: Nematoda): mitochondrial gene content, arrangement and composition compared with other Toxocara species. Mol Biochem Parasitol 2009; 166: 89–92.

169.Rai SK, Uga S, Wu Z, Takahashi Y, Matsumura T. Use of polymerase chain reaction in the diagnosis of toxocariasis: an experimental study. Southeast Asian J Trop Med Public Health 1997; 28: 541–44.

170.Ishiwata K, Shinohara A, Yagi K, Horii Y, Tsuchiya K, Nawa Y. Identification of tissue-embedded ascarid larvae by ribosomal DNA sequencing. Parasitol Res 2004; 92: 50–52.

171.Fogt-Wyrwas R, Jarosz W, Mizgajska-Wiktor H. Utilizing a polymerase chain reaction method for the detection of Toxocara canis and T. cati eggs in soil. J Helminthol 2007; 81: 75–78.

172.Pinelli E, Roelfsema JH, Brandes S, Kortbeek T. Detection and identification of Toxocara canis DNA in bronchoalveolar lavage of infected mice using a novel real-time PCR. Vet Parasitol 2013; 193: 337–41.

173.Zhu XQ, Gasser RB. Single-strand conformation polymorphism (SSCP)-based mutation scanning approaches to fingerprint sequence variation in ribosomal DNA of ascaridoid nematodes. Electrophoresis 1998; 19: 1366–73.

174.Macuhova K, Kumagai T, Akao N, Ohta N. Loop-mediated isothermal amplification assay for detection and discrimination of Toxocara canis and Toxocara cati eggs directly from sand samples. J Parasitol 2010; 96: 1224–27.

175.Zhu XQ, Jacobs DE, Chilton NB, Sani RA, Cheng NA, Gasser RB. Molecular characterization of a Toxocara variant from cats in Kuala Lumpur, Malaysia. Parasitology 1998; 117: 155–64.

176.Li MW, Zhu XQ, Gasser RB, et al. The occurrence of Toxocara malaysiensis in cats in China, confirmed by sequence-based analyses of ribosomal DNA. Parasitol Res 2006; 99: 554–47.

177.Magnaval JF, Fabre R, Maurières P, Charlet JP, de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res 1991; 77: 697–702.

178.Noordin R, Smith HV, Mohamad S, Maizels RM, Fong MY. Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis. Acta Trop 2005; 93: 57–62.

179.Watthanakulpanich D, Smith HV, Hobbs G, Whalley AJ, Billington D. Application of Toxocara canis excretory-secretory antigens and IgG subclass antibodies (IgG1-4) in serodiagnostic assays of human toxocariasis. Acta Trop 2008; 106: 90–95.

180.Mohamad S, Azmi NC, Noordin R. Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120). J Clin Microbiol 2009; 47: 1712–17.

181.Peixoto PL, Nascimento E, Cançado GG, et al. Identification of candidate antigens from adult stages of Toxocara canis for the serodiagnosis of human toxocariasis. Mem Inst Oswaldo Cruz 2011; 106: 200–06.

182.Jin Y, Shen C, Huh S, Sohn WM, Choi MH, Hong ST. Serodiagnosis of toxocariasis by ELISA using crude antigen of Toxocara canis larvae. Korean J Parasitol 2013; 51: 433–39.

183.Roldán WH, Elefant GR, Ferreira AW. Deglycosylation of Toxocara excretory-secretory antigens improves the specificity of the serodiagnosis for human toxocariasis. Parasite Immunol 2015; 37: 557–67.

184.Boldiš V, o­ndriska F, Špitalská E, Reiterová K. Immunodiagnostic approaches for the detection of human toxocarosis. Exp Parasitol 2015; 159: 252–58.

185.Elefant GR, Roldán WH, Seeböck A, Kosma P. Evaluation of a di-O-methylated glycan as a potential antigenic target for the serodiagnosis of human toxocariasis. Parasite Immunol 2016; 38: 236–43.

186.de Savigny DH, Voller A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol 1979; 32: 284–88.

187.Moreira GM, Telmo Pde L, Mendonça M, et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol 2014; 30: 456–64.

188.Anderson JP, Rascoe LN, Levert K, et al. Development of a luminex bead based assay for diagnosis of toxocariasis using recombinant antigens Tc-CTL-1 and Tc-TES-26. PLoS Negl Trop Dis 2015; 9: e0004168.

189.Zhan B, Ajmera R, Geiger SM, et al. Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis. Trop Med Int Health 2015; 20: 1787–96.

190.Hübner J, Uhlíková M, Leissová M. Diagnosis of the early phase of larval toxocariasis using IgG avidity. Epidemiol Mikrobiol Imunol 2001; 50: 67–70 (in Czech).

191.Magnaval JF, Berry A, Fabre R, Morassin B. Eosinophil cationic protein as a possible marker of active human Toxocara infection. Allergy 2001; 56: 1096–99.

192.Dziemian E, Zarnowska H, Kołodziej-Sobocińska M, Machnicka B. Determination of the relative avidity of the specific IgG antibodies in human toxocariasis. Parasite Immunol 2008; 30: 187–90.

193.Lee AC, Schantz PM, Kazacos KR, Montgomery SP, Bowman DD. Epidemiologic and zoonotic aspects of ascarid infections in dogs and cats. Trends Parasitol 2010; 26: 155–61.

194.Palmer CS, Thompson RC, Traub RJ, Rees R, Robertson ID. National study of the gastrointestinal parasites of dogs and cats in Australia. Vet Parasitol 2008; 151: 181–90.

195.Barutzki D, Schaper R. Results of parasitological examinations of faecal samples from cats and dogs in Germany between 2003 and 2010. Parasitol Res 2011; 109: S45–60.

196.Traub RJ, Robertson ID, Irwin PJ, Mencke N, Thompson RC. Canine gastrointestinal parasitic zoonoses in India. Trends Parasitol 2005; 21: 42–48.

197.Sowemimo OA. Prevalence and intensity of Toxocara canis (Werner, 1782) in dogs and its potential public health significance in Ile-Ife, Nigeria. J Helminthol 2007; 81: 433–38.

198.Dai RS, Li ZY, Li F, et al. Severe infection of adult dogs with helminths in Hunan Province, China poses significant public health concerns. Vet Parasitol 2009; 160: 348–50.

199.Waap H, Gomes J, Nunes T. Parasite communities in stray cat populations from Lisbon, Portugal. J Helminthol 2014; 88: 389–95.

200.Manini MP, Marchioro AA, Colli CM, Nishi L, Falavigna-Guilherme AL. Association between contamination of public squares and seropositivity for Toxocara spp. in children. Vet Parasitol 2012; 188: 48–52.

201.Dubná S, Langrová I, Jankovská I, et al. Contamination of soil with Toxocara eggs in urban (Prague) and rural areas in the Czech Republic. Vet Parasitol 2007; 144: 81–86.

202.Poeppl W, Herkner H, Tobudic S, et al. Exposure to Echinococcus multilocularis, Toxocara canis, and Toxocara cati in Austria: a nationwide cross-sectional seroprevalence study. Vector Borne Zoonotic Dis 2013; 13: 798–803.

203.Keegan JD, Holland CV. Contamination of the hair of owned dogs with the eggs of Toxocara spp. Vet Parasitol 2010; 173: 161–64.

204.Taira K, Saeed I, Permin A, Kapel CM. Zoonotic risk of Toxocara canis infection through consumption of pig or poultry viscera. Vet Parasitol 2004; 121: 115–24.

205.Dutra GF, Pinto NS, de Avila LF, et al. Risk of infection by the consumption of liver of chickens inoculated with low doses of Toxocara canis eggs. Vet Parasitol 2014; 203: 87–90.

206.Fillaux J, Magnaval JF. Laboratory diagnosis of human toxocariasis. Vet Parasitol 2013; 193: 327–36.

207.Wiśniewska-Ligier M, Woźniakowska-Gęsicka T, Sobolewska-Dryjańska J, Markiewicz-Jóźwiak A, Wieczorek M. Analysis of the course and treatment of toxocariasis in children-a long-term observation. Parasitol Res 2012; 110: 2363–71.

208.Caumes E. Treatment of cutaneous larva migrans and Toxocara infection. Fundam Clin Pharmacol 2003; 17: 213–16.

209.Barisani-Asenbauer T, Maca SM, Hauff W, et al. Treatment of ocular toxocariasis with albendazole. J Ocul Pharmacol Ther 2001; 17: 287–94.

210.Horiuchi A, Satou T, Akao N, Koike K, Fujita K, Nikaido T. The effect of free and polyethylene glycol-liposome-entrapped albendazole o­n larval mobility and number in Toxocara canis infected mice. Vet Parasitol 2005; 129: 83–87.

211.Hrckova G, Velebný S, Obwaller A, Auer H, Kogan G. Evaluation of follow-up of therapy with fenbendazole incorporated into stabilized liposomes and immunomodulator glucan in mice infected with Toxocara canis larvae. Acta Trop 2007; 104: 122–32.

212.Barrera MG, Leonardi D, Bolmaro RE, et al. In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans. Eur J Pharm 2010; 75: 451–54.

213.Stürchler D, Schubarth P, Gualzata M, Gottstein B, Oettli A. Thiabendazole vs albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol 1989; 83: 473–78.

214.Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology 1995; 110: 529–33.

215.Hrckova G, Velebný S. Treatment of Toxocara canis infections in mice with liposome-incorporated benzimidazole carbamates and immunomodulator glucan. J Helminthol 2001; 75: 141–46.

216.Leonardi D, Echenique C, Lamas MC, Salomon CJ. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection. J Antimicrob Chemother 2009; 64: 375–78.

217.Reis M, Trinca A, Ferreira MJ, Monsalve-Puello AR, Grácio MA. Toxocara canis: potential activity of natural products against second-stage larvae in vitro and in vivo. Exp Parasitol 2010; 126: 191–97.

218.Mata-Santos T, Pinto NF, Mata-Santos HA, et al. Anthelmintic activity of lapachol, β-lapachone and its derivatives against Toxocara canis larvae. Rev Inst Med Trop Sao Paulo 2015; 57: 197–204.

219.Garcia HH, Gonzalez AE, Tsang VC, et al. Elimination of Taenia solium transmission in northern Peru. N Engl J Med 2016; 374: 2335–44.

220.McSorley HJ, Maizels RM. Helminth infections and host immune regulation. Clin Microbiol Rev 2012; 25: 585–608.

221.Maizels RM. Toxocara canis: molecular basis of immune recognition and evasion. Vet Parasitol 2013; 193: 365–74.

222.Loukas A, Maizels RM. Helminth C-type lectins and host-parasite interactions. Parasitol Today 2000; 16: 333–39.

223.Długosz E, Wasyl K, Klockiewicz M, Wiśniewski M. Toxocara canis mucins among other excretory-secretory antigens induce in vitro secretion of cytokines by mouse splenocytes. Parasitol Res 2015; 114: 3365–71.

224.Maizels RM, de Savigny D, Ogilvie BM. Characterization of surface and excretory-secretory antigens of Toxocara canis infective larvae. Parasite Immunol 1984; 6: 23–37.

225.Loukas A, Mullin NP, Tetteh KK, Moens L, Maizels RM. A novel C-type lectin secreted by a tissue-dwelling parasitic nematode. Curr Biol 1999; 9: 825–28.

226.Loukas A, Hintz M, Linder D, et al. A family of secreted mucins from the parasitic nematode Toxocara canis bears diverse mucin domains but shares similar flanking six-cysteine repeat motifs. J Biol Chem 2000; 275: 39600–07.

227.Kennedy MW, Maizels RM, Meghji M, Young L, Qureshi F, Smith HV. Species-specific and common epitopes o­n the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvae. Parasite Immunol 1987; 9: 407–20.

228.Gems D, Maizels RM. An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins. Proc Natl Acad Sci USA 1996; 93: 1665–70.

229.Maizels RM, Tetteh KK, Loukas A. Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematode. Int J Parasitol 2000; 30: 495–508.

230.Zhu XQ, Korhonen PK, Cai H, et al. Genetic blueprint of the zoonotic pathogen Toxocara canis. Nat Commun 2015; 6: 6145.

231.Gasser RB, Korhonen PK, Zhu XQ, Young ND. Harnessing the Toxocara genome to underpin toxocariasis research and new interventions. Adv Parasitol 2016; 91: 87–110.

232.Del Prete GF, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88: 346–50.

233.Mazur-Melewska K, Figlerowicz M, Cwalińska A, et al. Production of interleukins 4 and 10 in children with hepatic involvement in the course of Toxocara spp. infection. Parasite Immunol 2016; 38: 101–07.

234.Yariktas M, Demirci M, Aynali G, Kaya S, Doner F. Relationship between Toxocara seropositivity and allergic rhinitis. Am J Rhinol 2007; 21: 248–50.

235.Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 2009; 167: 1–11.

236.Nagy D, Bede O, Danka J, Szénási Z, Sipka S. Analysis of serum cytokine levels in children with chronic cough associated with Toxocara canis infection. Parasite Immunol 2012; 34: 581–88.

237.Kuroda E, Yoshida Y, En Shan B, Yamashita U. Suppression of macrophage interleukin-12 and tumour necrosis factor-α production in mice infected with Toxocara canis. Parasite Immunol 2001; 23: 305–11.

238.Fattah DI, Maizels RM, McLaren DJ, Spry CJ. Toxocara canis: interaction of human blood eosinophils with the infective larvae. Exp Parasitol 1986; 61: 421–31.

239.Buck AH, Coakley G, Simbari F, et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian ce.

240.Deutz A, Fuchs K, Auer H, Kerbl U, Aspöck H, Köfer J. Toxocara-infestations in Austria: a study o­n the risk of infection of farmers, slaughterhouse staff, hunters and veterinarians. Parasitol Res 2005; 97: 390–94.

241.Fan CK, Liao CW, Cheng YC. Factors affecting disease manifestation of toxocarosis in humans: genetics and environment. Vet Parasitol 2013; 193: 342–52.

242.Morgan ER, Azam D, Pegler K. Quantifying sources of environmental contamination with Toxocara spp. eggs. Vet Parasitol 2013; 193: 390–97.

243.Nijsse R, Ploeger HW, Wagenaar JA, Mughini-Gras L. Toxocara canis in household dogs: prevalence, risk factors and owners’ attitude towards deworming. Parasitol Res 2014; 114: 561–69.

244.Overgaauw PA, van Knapen F. Veterinary and public health aspects of Toxocara spp. Vet Parasitol 2013; 193: 398–403.

245.Atenstaedt RL, Jones S. Interventions to prevent dog fouling: a systematic review of the evidence. Public Health 2011; 125: 90–92.

246.Nijsse R, Mughini-Gras L, Wagenaar JA, Franssen F, Ploeger HW. Environmental contamination with Toxocara eggs: a quantitative approach to estimate the relative contributions of dogs, cats and foxes, and to assess the efficacy of advised interventions in dogs. Parasit Vectors 2015; 8: 397.

247.Ma G, Luo Y, Zhu H, et al. MicroRNAs of Toxocara canis and their predicted functional roles. Parasit Vectors 2016; 9: 229.

248.Manzano-Román R, Siles-Lucas M. MicroRNAs in parasitic diseases: potential for diagnosis and targeting. Mol Biochem Parasitol 2012; 186: 81–86.

249.Hoy AM, Lundie RJ, Ivens A, et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. PLoS Negl Trop Dis 2014; 8: e2701.

250.Britton C, Winter AD, Marks ND, et al. Application of small RNA technology for improved control of parasitic helminths. Vet Parasitol 2015; 212: 47–53.

251.Woodhall DM, Eberhard ML, Parise ME. Neglected parasitic infections in the United States: toxocariasis. Am J Trop Med Hyg 2014; 90: 810–13.

252.Schabussova I, Amer H, van Die I, Kosma P, Maizels RM. O-methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections. Int J Parasitol 2007; 37: 97–109.

253.Tritten L, Burkman E, Moorhead A, et al. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS Negl Trop Dis 2014; 8: e2971.

254.Quintana JF, Makepeace BL, Babayan SA, et al. Extracellular o­nchocerca-derived small RNAs in host nodules and blood. Parasit Vectors 2015; 8: 58.

255.Ma GX, Zhou RQ, Song ZH, Zhu HH, Zhou ZY, Zeng YQ. Molecular mechanism of serine/threonine protein phosphatase 1 (PP1ca-PP1r7) in spermatogenesis of Toxocara canis. Acta Trop 2015; 149: 148–54.

256.McCoy CJ, Warnock ND, Atkinson LE, et al. RNA interference in adult Ascaris suum—an opportunity for the development of a functional genomics platform that supports organism-, tissue-and cell-based biology in a nematode parasite. Int J Parasitol 2015; 45: 673–78.

Các nội dung khác »

---